tyramine has been researched along with rosiglitazone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bizou, M; Carpéné, C; Grès, S; Hasnaoui, M; Tréguer, K | 1 |
Armando, AM; Chi, NW; Chi, TJ; Evans, RM; Hah, N; Oh, DY; Olefsky, JM; Osborn, O; Paschoal, VA; Pessentheiner, AR; Quehenberger, O; Talukdar, S; Tye, GL; Walenta, E | 1 |
1 review(s) available for tyramine and rosiglitazone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for tyramine and rosiglitazone
Article | Year |
---|---|
Glitazones inhibit human monoamine oxidase but their anti-inflammatory actions are not mediated by VAP-1/semicarbazide-sensitive amine oxidase inhibition.
Topics: Adipocytes; Adult; Amine Oxidase (Copper-Containing); Anti-Inflammatory Agents; Benzylamines; Cell Adhesion Molecules; Drug Evaluation, Preclinical; Female; Humans; Hydrogen Peroxide; Middle Aged; Monoamine Oxidase Inhibitors; Pioglitazone; Rosiglitazone; Subcutaneous Fat; Thiazolidinediones; Tyramine | 2015 |
Positive Reinforcing Mechanisms between GPR120 and PPARγ Modulate Insulin Sensitivity.
Topics: 3T3-L1 Cells; Acetates; Adipocytes; Animals; Cells, Cultured; Female; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; PPAR gamma; Receptors, G-Protein-Coupled; Rosiglitazone; Tyramine | 2020 |